3% trehalose eye drops for corneal barrier protection

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a randomized contralateral eye-controlled trial enrolling adults with moderate-to-severe dry eye, where one eye receives a 3% trehalose ophthalmic solution and the other eye receives sterile buffered saline. Participants undergo standardized clinical examinations at baseline and after one month, including symptom questionnaires, tear and ocular surface measurements, Schirmer testing when applicable, and fluorometry to measure sodium fluorescein penetration. The primary outcome focuses on relative corneal epithelial barrier function as indicated by dye penetration, with secondary assessments of signs and symptoms of dry eye. All treatments are administered topically and compared within-subject to minimize variability.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Adult subjects, \> age 18 years, with moderate-to-severe dry eye, defined as fitting criteria for dry eye stages 3 or 4 of the MGD Workshop Management and Treatment subcommittee report.
* Subjects must have normal eyelid position and closure.
* For enrollment as aqueous tear deficiency, subjects must have a Schirmer I result of \< 5.0 mm wetting in 5 minutes without anesthesia.

Exclusion Criteria:

* History or evidence of ocular or intraocular surgery in either eye within the past twelve months. LASIK and other kerato-refractive procedure patients can qualify if the most recent surgery or enhancement was 12 or more months prior.
* History or evidence of serious ocular trauma in either eye within the past six months.
* History of hypersensitivity to any component of the study medications.
* History or evidence of epithelial herpes simplex keratitis (dendritic keratitis); vaccinia, active or recent varicella, viral disease of the cornea and/or conjunctiva; chronic bacterial disease of the cornea and/or conjunctiva; mycobacterial infection of the eye; and/or fungal disease of the eye.
* History or evidence of active ocular allergy.
* Females who are pregnant, nursing, or planning a pregnancy during the study.
* Evidence of greater than mild eyelid deformity (e.g., ectropion, entropion, ptosis).
* Use of concomitant topical ocular medications during the study duration.
* Individuals using systemic steroids, immunosuppressive agents and/or anti-cholinergic (e.g. cold and allergy medications, tricyclic antidepressants) for treatment of autoimmune connective tissue disease may not be enrolled in the study if they have not been on a stable dosing regimen for a minimum of 30 days prior to the visit.
* Individuals with uncontrolled diabetes or history or evidence of peripheral neuropathy.
* Active intraocular inflammatory conditions such as iritis.
* Individuals wearing rigid gas permeable or scleral contact lenses within the previous six months of enrollment. Subjects can have worn soft lenses, but not within one month prior to enrollment.
* Individuals using punctual plugs inserted within 30 days of study start.

Where it's running

• Marshall B. Ketchum University
  Fullerton, California, United States Recruiting

Study contacts

• Study coordinator: Shora Ansari, OD, MS
• Email: sansari@ketchum.edu
• Phone: 714-463-7536

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Can cyclosporine 0.1% eye drops improve comfort for contact lens wearers with dry eye

  This study tests whether a water-free cyclosporine eye drop (VEVYE) can reduce dry eye symptoms and improve comfort for adults who wear soft contact lenses.

  Recruiting Ocular Aesthetics, LLC dba Ocular Clinical Trials · Houston, Texas · NCT07904728

• Association Between Periodontitis and Dry Eye Disease in Adults

  This study tests whether periodontitis and dry eye disease are linked by comparing groups with and without each condition.

  Recruiting University of Sulaimani · Sulaymaniyah, As Sulaymaniyah Governorate · NCT07873697

• Brillouin hydration mapping to study cornea health

  Researchers test a Brillouin microscope to see if it can measure corneal water content in healthy people and those with eye conditions.

  Recruiting Massachusetts General Hospital · Boston, Massachusetts · NCT07780890

• Is Systane PRO Preservative Free as good as Blink Triple Care Preservative Free for dry eye symptoms

  This study tests whether Systane PRO Preservative Free works as well as Blink Triple Care Preservative Free to improve dry eye symptoms in adults over 4 weeks.

  Recruiting Phase 4 Gordon Schanzlin New Vision · La Jolla, California · NCT07745062

• TRYPTYR eye drops for dry eye disease

  This study tests TRYPTYR eye drops to see if they improve dry eye symptoms in adults with Dry Eye Disease.

  Recruiting Phase 4 NYU Langone Health · New York, New York · NCT07732010

• OTC lubricating eye drops for dry eye disease: tolerability and vision outcomes

  This trial tests whether a preservative-free OTC eye drop mix can be tolerated and improve symptoms and visual comfort in adults with dry eye disease.

  Recruiting Phase 4 Andover Research Eye Institute · Andover, Massachusetts · NCT07676084

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.